Clinical Trial
Levamisole and the treatment of Herpesvirus hominis infections. A case report
- PMID: 354039
Item in Clipboard
Clinical Trial
Levamisole and the treatment of Herpesvirus hominis infections. A case report
S Afr Med J.
.
Abstract
The successful treatment with levamisole of 3 categories of Herpesvirus hominis infection is described. A fourth category of patients infected with vulval condylomata acuminata were unsuccessfully treated with levamisole. The dosage regimen is discussed. The most dramatic feature was the relief of the severe pain encountered in the acute cases. Levamisole has also prevented further attacks to date. There is no doubt that levamisole has a definite place in the treatment of H. hominis infections.
Similar articles
-
Recurrent herpes infections and levamisole.Rev Latinoam Microbiol. 1976 Oct-Dec;18(4):225-6. Rev Latinoam Microbiol. 1976. PMID: 801844 Clinical Trial. No abstract available.
-
Double-blind cross-over study of levamisole as immunoprophylaxis for recurrent herpes progenitalis.Cutis. 1978 Mar;21(3):352-4. Cutis. 1978. PMID: 343999 Clinical Trial.
-
Treatment with levamisole of recurrent herpes genitalis.Antimicrob Agents Chemother. 1978 May;13(5):809-12. doi: 10.1128/AAC.13.5.809. Antimicrob Agents Chemother. 1978. PMID: 208462 Free PMC article. Clinical Trial.
-
Levamisole in chronic inflammatory diseases.J Rheumatol Suppl. 1978;4:101-13. J Rheumatol Suppl. 1978. PMID: 366135 Review.
-
Treatment of anogenital condylomata acuminata with topical photodynamic therapy: report of 14 cases and review.Int J Infect Dis. 2010 Sep;14 Suppl 3:e280-2. doi: 10.1016/j.ijid.2009.11.031. Epub 2010 Mar 25. Int J Infect Dis. 2010. PMID: 20346722 Review.